Report cover image

Nanotech Drug Implants Market Forecasts to 2032 – Global Analysis By Product Type (Biodegradable Implants, Non-biodegradable Implants and Smart/Active Implants), Material (Polymers, Lipid-based, Metallic/Inorganic and Other Materials), Therapeutic Area, I

Publisher Stratistics Market Research Consulting
Published Sep 15, 2025
Length 200 Pages
SKU # SMR20398567

Description

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Nanotech Drug Implants Market, By Product Type
5.1 Introduction
5.2 Biodegradable implants
5.3 Non-biodegradable implants
5.4 Smart/active implants
6 Global Nanotech Drug Implants Market, By Material
6.1 Introduction
6.2 Polymers
6.3 Lipid-based
6.4 Metallic/inorganic
6.5 Other Materials
7 Global Nanotech Drug Implants Market, By Therapeutic Area
7.1 Introduction
7.2 Oncology
7.3 Neurology
7.4 Cardiovascular
7.5 Endocrinology
7.6 Ophthalmology
7.7 Infectious diseases
7.8 Other Therapeutic Areas
8 Global Nanotech Drug Implants Market, By Implantation Site
8.1 Introduction
8.2 Subcutaneous
8.3 Intracranial
8.4 Intraperitoneal
8.5 Intraocular
8.6 Other sites
9 Global Nanotech Drug Implants Market, By End User
9.1 Introduction
9.2 Hospitals & clinics
9.3 Specialty care centers
9.4 Ambulatory surgical centers
10 Global Nanotech Drug Implants Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Abbott
12.2 AstraZeneca
12.3 Bristol-Myers Squibb
12.4 Celgene Corporation
12.5 Johnson & Johnson
12.6 Merck
12.7 Moderna
12.8 Nanobiotix
12.9 Nanoform
12.10 Novartis
12.11 Pfizer
12.12 Roche
12.13 Sanofi
12.14 Thermo Fisher Scientific
12.15 Medtronic
12.16 Straumann Holding
12.17 Gilead Sciences
12.18 Jazz Pharmaceuticals
List of Tables
Table 1 Global Nanotech Drug Implants Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global Nanotech Drug Implants Market Outlook, By Product Type (2024-2032) ($MN)
Table 3 Global Nanotech Drug Implants Market Outlook, By Biodegradable implants (2024-2032) ($MN)
Table 4 Global Nanotech Drug Implants Market Outlook, By Non-biodegradable implants (2024-2032) ($MN)
Table 5 Global Nanotech Drug Implants Market Outlook, By Smart/active implants (2024-2032) ($MN)
Table 6 Global Nanotech Drug Implants Market Outlook, By Material (2024-2032) ($MN)
Table 7 Global Nanotech Drug Implants Market Outlook, By Polymers (2024-2032) ($MN)
Table 8 Global Nanotech Drug Implants Market Outlook, By Lipid-based (2024-2032) ($MN)
Table 9 Global Nanotech Drug Implants Market Outlook, By Metallic/inorganic (2024-2032) ($MN)
Table 10 Global Nanotech Drug Implants Market Outlook, By Other Materials (2024-2032) ($MN)
Table 11 Global Nanotech Drug Implants Market Outlook, By Therapeutic Area (2024-2032) ($MN)
Table 12 Global Nanotech Drug Implants Market Outlook, By Oncology (2024-2032) ($MN)
Table 13 Global Nanotech Drug Implants Market Outlook, By Neurology (2024-2032) ($MN)
Table 14 Global Nanotech Drug Implants Market Outlook, By Cardiovascular (2024-2032) ($MN)
Table 15 Global Nanotech Drug Implants Market Outlook, By Endocrinology (2024-2032) ($MN)
Table 16 Global Nanotech Drug Implants Market Outlook, By Ophthalmology (2024-2032) ($MN)
Table 17 Global Nanotech Drug Implants Market Outlook, By Infectious diseases (2024-2032) ($MN)
Table 18 Global Nanotech Drug Implants Market Outlook, By Other Therapeutic Areas (2024-2032) ($MN)
Table 19 Global Nanotech Drug Implants Market Outlook, By Implantation Site (2024-2032) ($MN)
Table 20 Global Nanotech Drug Implants Market Outlook, By Subcutaneous (2024-2032) ($MN)
Table 21 Global Nanotech Drug Implants Market Outlook, By Intracranial (2024-2032) ($MN)
Table 22 Global Nanotech Drug Implants Market Outlook, By Intraperitoneal (2024-2032) ($MN)
Table 23 Global Nanotech Drug Implants Market Outlook, By Intraocular (2024-2032) ($MN)
Table 24 Global Nanotech Drug Implants Market Outlook, By Other sites (2024-2032) ($MN)
Table 25 Global Nanotech Drug Implants Market Outlook, By End User (2024-2032) ($MN)
Table 26 Global Nanotech Drug Implants Market Outlook, By Hospitals & clinics (2024-2032) ($MN)
Table 27 Global Nanotech Drug Implants Market Outlook, By Specialty care centers (2024-2032) ($MN)
Table 28 Global Nanotech Drug Implants Market Outlook, By Ambulatory surgical centers (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Table of Contents

200 Pages
1 Executive Summary 2 Preface 2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.4.1 Data Mining 2.4.2 Data Analysis 2.4.3 Data Validation 2.4.4 Research Approach 2.5 Research Sources 2.5.1 Primary Research Sources 2.5.2 Secondary Research Sources 2.5.3 Assumptions 3 Market Trend Analysis 3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 Product Analysis 3.7 End User Analysis 3.8 Emerging Markets 3.9 Impact of Covid-19 4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Nanotech Drug Implants Market, By Product Type 5.1 Introduction 5.2 Biodegradable implants 5.3 Non-biodegradable implants 5.4 Smart/active implants 6 Global Nanotech Drug Implants Market, By Material 6.1 Introduction 6.2 Polymers 6.3 Lipid-based 6.4 Metallic/inorganic 6.5 Other Materials 7 Global Nanotech Drug Implants Market, By Therapeutic Area 7.1 Introduction 7.2 Oncology 7.3 Neurology 7.4 Cardiovascular 7.5 Endocrinology 7.6 Ophthalmology 7.7 Infectious diseases 7.8 Other Therapeutic Areas 8 Global Nanotech Drug Implants Market, By Implantation Site 8.1 Introduction 8.2 Subcutaneous 8.3 Intracranial 8.4 Intraperitoneal 8.5 Intraocular 8.6 Other sites 9 Global Nanotech Drug Implants Market, By End User 9.1 Introduction 9.2 Hospitals & clinics 9.3 Specialty care centers 9.4 Ambulatory surgical centers 10 Global Nanotech Drug Implants Market, By Geography 10.1 Introduction 10.2 North America 10.2.1 US 10.2.2 Canada 10.2.3 Mexico 10.3 Europe 10.3.1 Germany 10.3.2 UK 10.3.3 Italy 10.3.4 France 10.3.5 Spain 10.3.6 Rest of Europe 10.4 Asia Pacific 10.4.1 Japan 10.4.2 China 10.4.3 India 10.4.4 Australia 10.4.5 New Zealand 10.4.6 South Korea 10.4.7 Rest of Asia Pacific 10.5 South America 10.5.1 Argentina 10.5.2 Brazil 10.5.3 Chile 10.5.4 Rest of South America 10.6 Middle East & Africa 10.6.1 Saudi Arabia 10.6.2 UAE 10.6.3 Qatar 10.6.4 South Africa 10.6.5 Rest of Middle East & Africa 11 Key Developments 11.1 Agreements, Partnerships, Collaborations and Joint Ventures 11.2 Acquisitions & Mergers 11.3 New Product Launch 11.4 Expansions 11.5 Other Key Strategies 12 Company Profiling 12.1 Abbott 12.2 AstraZeneca 12.3 Bristol-Myers Squibb 12.4 Celgene Corporation 12.5 Johnson & Johnson 12.6 Merck 12.7 Moderna 12.8 Nanobiotix 12.9 Nanoform 12.10 Novartis 12.11 Pfizer 12.12 Roche 12.13 Sanofi 12.14 Thermo Fisher Scientific 12.15 Medtronic 12.16 Straumann Holding 12.17 Gilead Sciences 12.18 Jazz Pharmaceuticals List of Tables Table 1 Global Nanotech Drug Implants Market Outlook, By Region (2024-2032) ($MN) Table 2 Global Nanotech Drug Implants Market Outlook, By Product Type (2024-2032) ($MN) Table 3 Global Nanotech Drug Implants Market Outlook, By Biodegradable implants (2024-2032) ($MN) Table 4 Global Nanotech Drug Implants Market Outlook, By Non-biodegradable implants (2024-2032) ($MN) Table 5 Global Nanotech Drug Implants Market Outlook, By Smart/active implants (2024-2032) ($MN) Table 6 Global Nanotech Drug Implants Market Outlook, By Material (2024-2032) ($MN) Table 7 Global Nanotech Drug Implants Market Outlook, By Polymers (2024-2032) ($MN) Table 8 Global Nanotech Drug Implants Market Outlook, By Lipid-based (2024-2032) ($MN) Table 9 Global Nanotech Drug Implants Market Outlook, By Metallic/inorganic (2024-2032) ($MN) Table 10 Global Nanotech Drug Implants Market Outlook, By Other Materials (2024-2032) ($MN) Table 11 Global Nanotech Drug Implants Market Outlook, By Therapeutic Area (2024-2032) ($MN) Table 12 Global Nanotech Drug Implants Market Outlook, By Oncology (2024-2032) ($MN) Table 13 Global Nanotech Drug Implants Market Outlook, By Neurology (2024-2032) ($MN) Table 14 Global Nanotech Drug Implants Market Outlook, By Cardiovascular (2024-2032) ($MN) Table 15 Global Nanotech Drug Implants Market Outlook, By Endocrinology (2024-2032) ($MN) Table 16 Global Nanotech Drug Implants Market Outlook, By Ophthalmology (2024-2032) ($MN) Table 17 Global Nanotech Drug Implants Market Outlook, By Infectious diseases (2024-2032) ($MN) Table 18 Global Nanotech Drug Implants Market Outlook, By Other Therapeutic Areas (2024-2032) ($MN) Table 19 Global Nanotech Drug Implants Market Outlook, By Implantation Site (2024-2032) ($MN) Table 20 Global Nanotech Drug Implants Market Outlook, By Subcutaneous (2024-2032) ($MN) Table 21 Global Nanotech Drug Implants Market Outlook, By Intracranial (2024-2032) ($MN) Table 22 Global Nanotech Drug Implants Market Outlook, By Intraperitoneal (2024-2032) ($MN) Table 23 Global Nanotech Drug Implants Market Outlook, By Intraocular (2024-2032) ($MN) Table 24 Global Nanotech Drug Implants Market Outlook, By Other sites (2024-2032) ($MN) Table 25 Global Nanotech Drug Implants Market Outlook, By End User (2024-2032) ($MN) Table 26 Global Nanotech Drug Implants Market Outlook, By Hospitals & clinics (2024-2032) ($MN) Table 27 Global Nanotech Drug Implants Market Outlook, By Specialty care centers (2024-2032) ($MN) Table 28 Global Nanotech Drug Implants Market Outlook, By Ambulatory surgical centers (2024-2032) ($MN) Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us